


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+6.21%
+16.02%
+9.46%
-6.43%
+12.64%
PGEN
Precigen
$5.90

Login to see Precigen (PGEN) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Investors confidence is positive
PGEN Price Performance
$3.86 (+52.85%)
$3.94 (+49.75%)
$4.56 (+29.39%)
$1.85 (+218.92%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
PGEN Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
PGEN Street Sentiment is extremely bullish and have negative views on the near-term outlook
PGEN has Extreme risk level

Sentiments overview associated with events and the stock performance
NUVB
Nuvation Bio Inc.
5.53
-2.21%
NUVL
Nuvalent
123.50
-0.02%
NVO
Novo Nordisk A/S
48.15
+0.15%
SVRA
Savara
5.95
+0.76%
What is PGEN current stock price?
What is PGEN current Stock IQ?
What is PGEN RSI signal right now?
What is PGEN analyst price target and upside potential?
What do analysts say about PGEN stock?
What is PGEN momentum trend right now?
What are PGEN stock strengths?
What is PGEN Risk Level?
Should I buy PGEN stock right now?
Is PGEN a Strong Buy right now?
What is PGEN market cap and volume?
What factors influence PGEN's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
PGEN
Precigen
Current Price
$5.90
NUVB
Nuvation Bio Inc.
5.53
-2.21%
NUVL
Nuvalent
123.50
-0.02%
NVO
Novo Nordisk A/S
48.15
+0.15%
SVRA
Savara
5.95
+0.76%

PGEN Price Performance
$3.86 (+52.85%)
$3.94 (+49.75%)
$4.56 (+29.39%)
$1.85 (+218.92%)
PGEN Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
PGEN Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
PGEN Street Sentiment is extremely bullish and have negative views on the near-term outlook
PGEN has Extreme risk level

PGEN Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Investors confidence is positive
PGEN Trading Signals
PGEN is now at $5.86, up +6.16% from $5.52. This rapid movement warrants attention.
PGEN at $5.86 is within 1.51% of its 52-week high of $5.95. This proximity suggests potential breakout zone ahead.
PGEN is experiencing a volume spike with 10.50M shares traded, 2.01x its average volume of 5.22M. This indicates strong buying pressure.
PGEN is showing high volatility with an intraday swing of 8.58% (High: $5.95, Low: $5.48). This signals potential opportunities.
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PGEN Stock trends
PGEN Stock performance
PGEN Stock analysis
PGEN investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.